An outside the united states customer obtained a discordant elevated advia centaur xpt - total hcg (thcg) result for a pregnant female patient.The initial result was reported to the physician, who questioned the results.The sample was remeasured twice on same advia centaur xpt, and the results were lower.This sample was also diluted onboard with the dilutions of 1:10, 1:100 and 1:200 and all the diluted results resulted as errors.Quality control was in range at the time of testing and no instrument errors were found with the system during this event.The interpretation of results section of the advia centaur xpt total hcg instructions for use states: "results of this assay should always be interpreted in conjunction with patient's medical history, clinical presentation and other findings." siemens continues to investigate.
|
The customer obtained a discordant elevated advia centaur xpt - total hcg (thcg) result for a pregnant female patient.The initial result was reported to the physician, who questioned the results.The sample was remeasured twice on same advia centaur xpt, and the results were lower.There are no reports that treatment was altered or prescribed or adverse health consequences due to the discordant advia centaur xpt total hcg result.
|
Initial mdr 1219913-2023-00044 was filed on (b)(6) 2023 reporting a customer from outside the united states obtained a discordant elevated advia centaur xpt - total hcg (thcg) result for a pregnant female patient.The initial result was reported to the physician, who questioned the results.The sample was remeasured twice on same advia centaur xpt, and the results were lower.This sample was also diluted onboard with the dilutions of 1:10, 1:100 and 1:200 and all the diluted results resulted as errors.Additional information - (b)(6) 2023.The customer observed a falsely elevated, non-reproducible total human chorionic gonadotropin (thcg) patient sample using reagent lot 341 on an advia centaur xpt.On (b)(6) 2023, an initial thcg result of 670.2 miu/ml was reported to the physician and questioned.The sample was re-centrifuged and repeated, which produced results of 45.4 miu/ml and 56.5 miu/ml, the former of which was reported to and accepted by the physician.Biorad controls were within expected ranges, and no instrument errors were reported during the day of this event.There were no issues with other samples tested on the day of this event.The instrument was serviced on (b)(6) 2023 in which reagent probes were recalibrated, and the reagent mixer and acid/base pumps were checked.These service actions are considered normal troubleshooting for an issue of this nature.Thcg precision was verified following service and was acceptable.Based on available information, the cause of the discordant result is consistent with sample integrity and/or a sample handling issue.No potential product issue is observed.The customer is operational.In section h6, the investigation finding, and investigation conclusion codes were updated.
|